![]() |
市场调查报告书
商品编码
1953452
外科牵开器市场 - 全球产业规模、份额、趋势、机会及预测(按类型、产品、应用、地区和竞争格局划分,2021-2031年)Surgical Retractors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By Application, By Region & Competition, 2021-2031F |
||||||
全球外科牵开器市场预计将从 2025 年的 15.2 亿美元成长到 2031 年的 19.9 亿美元,复合年增长率为 4.59%。
这些专用医疗器械对于分离切口边缘、保护皮下组织和器官至关重要,能够为外科医师提供最佳的手术视野和操作空间。推动市场成长的关键因素包括全球人口老化以及需要手术介入的慢性疾病盛行率不断上升。此外,全球手术数量的持续成长也促进了对这些关键器械的持续需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 15.2亿美元 |
| 市场规模:2031年 | 19.9亿美元 |
| 复合年增长率:2026-2031年 | 4.59% |
| 成长最快的细分市场 | 手持式 |
| 最大的市场 | 北美洲 |
然而,由于严格的消毒监管以及可重复使用医疗设备相关的手术部位感染风险,市场面临巨大的挑战。医疗机构必须不断权衡这些严格的安全通讯协定与成本限制和营运效率之间的关係。医疗资源的紧张状况体现在对外科专家的巨大需求上。根据美国医学院协会预测,到2024年,美国将需要约16万名外科医生才能满足其人口的医疗保健需求。
微创手术中专用牵开器的日益普及是推动该市场发展的关键因素,从根本上改变了全球医院的器械需求。现代外科手术通讯协定优先考虑能够最大限度减少患者身体不适的技术,这就要求牵开器具备高精度、低轮廓的特点,能够在有限的手术视野内有效发挥作用。机器人辅助手术的普及就清晰地体现了这一转变,这类手术利用客製化设计的牵开系统(通常是手动或自动的)来增强手术视野,而无需进行大切口。根据Intuitive Surgical公司于2024年2月发布的2023年10-K报告,全球达文西手术量年增约22%。这种高难度手术的成长与对相容的、通常符合人体工学或具有照明功能的器械的需求直接相关,以确保在复杂的内部操作过程中的安全。
同时,对重组和美容手术的需求不断增长,推动了专用于美容用途的牵引装置的采购。这些装置必须确保最佳的手术视野,同时最大限度地减少组织损伤,以维持美容效果,并且需要各种形状和尺寸,以适应体型雕塑、乳房和脸部手术等不同需求。正如国际美容整形外科学会于2024年6月发布的《2023年全球调查结果》中所述,预计全球整形外科医师将进行约1,580万例手术,显示这些装置的应用领域十分广阔。如此高频率的择期手术迫使医疗机构维持大量的耐用医疗设备库存。因此,外科器械的总投资仍居高不下。据史赛克公司称,其医疗外科和神经技术部门2024年的净销售额为118亿美元,反映出该公司持续对必要的外科耗材和技术进行大量资本投入。
严格的消毒法规以及可重复使用器械相关的手术部位感染风险,对全球手术牵开器市场构成了重大障碍。监管机构日益强制要求实施严格且耗时的再处理通讯协定,以降低复杂手术器械固有的污染风险。这些要求迫使医疗机构在专业消毒基础设施和人事费用投入巨资,显着增加了可重复使用牵开器的营运成本和处理时间。这导致手术流程效率低下,进而造成手术量减少,并使医疗机构不愿增加其先进可重复使用器械的库存。
消毒失败造成的严重经济损失进一步加剧了营运负担。当再处理通讯协定不完全时,所引发的感染疾病会耗尽医院预算,而这些预算原本可以用来购买新设备。根据感染控制与流行病学专业人员协会 (APIC) 统计,到 2024 年,手术部位感染会使平均住院时间延长约 10 天,并导致每位患者额外支出约 2 万美元。如此巨大的经济负担迫使医疗机构优先考虑感染控制合规性和纠正措施,而非购买新的手术器械,直接阻碍了整个市场的成长。
为减少手术部位感染并简化繁琐的再处理流程,一次性牵开器的日益普及正在重塑市场格局。这些器材越来越多地整合了先进功能,例如无线LED照明,无需光纤电缆即可增强对深腔的可视性。领先製造商的财务表现也印证了这一转变,他们正投资于一次性技术以满足更高的灭菌标准。根据库柏公司(Cooper Companies)在2025年5月举行的「2025年第二季公布财报」中透露,其旗下OBP Surgical品牌的无线一次性手术牵开器产品组合实现了31%的收入增长,凸显了这些无菌即用型器械在临床环境中的快速普及。
同时,随着急诊手术从住院部转向门诊部,门诊手术中心(ASC)对小型牵开器系统的需求也在加速成长。这种转变需要专门设计、节省空间的器械,以便在门诊手术中心精简的基础设施内进行复杂的整形外科和重组手术。例如,门诊关节置换术的扩展需要坚固耐用且符合人体工学的牵开器,以便在较小的手术室中有效运作。根据果冻 Partners 公司 2025 年 11 月的“2025 年第三季度财报电话会议”,该公司门诊机构的年度累计全关节置换术同比增长 23%,表明门诊手术室对专用牵开器的需求显着增长。
The Global Surgical Retractors Market is projected to expand from USD 1.52 Billion in 2025 to USD 1.99 Billion by 2031, registering a CAGR of 4.59%. These specialized medical instruments are essential for separating incision edges and restraining underlying tissues or organs, thereby affording surgeons optimal visibility and access to the operative field. The primary factors driving this market growth include the globally aging population and the rising prevalence of chronic diseases that require surgical intervention. Furthermore, the worldwide increase in surgical procedure volumes serves as a foundational catalyst for the sustained demand for these critical tools.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.52 Billion |
| Market Size 2031 | USD 1.99 Billion |
| CAGR 2026-2031 | 4.59% |
| Fastest Growing Segment | Handheld |
| Largest Market | North America |
However, the market faces a significant challenge due to the stringent regulatory landscape concerning sterilization and the associated risks of surgical site infections linked to reusable devices. Healthcare providers must constantly balance these rigorous safety protocols against cost constraints and operational efficiency. This strain on medical resources is highlighted by the immense demand for surgical professionals; according to the Association of American Medical Colleges, the United States required approximately 160,000 surgeons in 2024 to meet the population's medical needs.
Market Driver
The increasing adoption of specialized retractors for minimally invasive surgery serves as a major market accelerator, fundamentally changing instrumentation requirements for hospitals globally. Modern surgical protocols increasingly prioritize techniques that minimize patient trauma, requiring high-precision, low-profile retractors that function effectively within confined operative fields. This shift is clearly demonstrated by the surge in robotic-assisted procedures, which utilize distinct, often specialized manual or automated retraction systems to maintain visualization without large incisions. According to Intuitive Surgical's February 2024 '2023 Annual Report on Form 10-K', worldwide da Vinci procedures grew approximately 22% compared to the previous year. This increase in advanced procedural volumes directly correlates with the need for compatible, often ergonomic or illuminated, instrumentation to ensure safety during complex internal maneuvers.
Simultaneously, the rising demand for reconstructive and cosmetic surgical procedures drives the procurement of specific retraction devices designed for aesthetic applications. These instruments must ensure optimal exposure while minimizing tissue damage to preserve aesthetic outcomes, necessitating a diverse range of geometries and sizes for body contouring, breast, and facial operations. As noted by the International Society of Aesthetic Plastic Surgery in its 'Global Survey 2023 Results' published in June 2024, plastic surgeons performed approximately 15.8 million surgical procedures worldwide, indicating a robust application area for these tools. This high volume of elective surgeries compels facilities to maintain extensive inventories of durable medical equipment. Consequently, general investment in surgical hardware remains high; according to Stryker, in 2024, the MedSurg and Neurotechnology segment reported net sales of $11.8 billion for the preceding fiscal year, reflecting substantial ongoing capital allocation toward essential surgical supplies and technologies.
Market Challenge
The stringent regulatory landscape regarding sterilization and the associated risk of surgical site infections with reusable devices presents a formidable barrier to the Global Surgical Retractors Market. Regulatory bodies increasingly mandate rigorous, time-consuming reprocessing protocols to mitigate contamination risks inherent in complex surgical instruments. These requirements compel healthcare facilities to invest heavily in specialized sterilization infrastructure and labor, significantly increasing the operational cost and turnaround time associated with reusable retractors. Consequently, the efficiency of surgical workflows is compromised, leading to reduced procedure throughput and a hesitancy among providers to expand their inventory of advanced reusable instrumentation.
This operational strain is compounded by the severe financial implications of sterilization failures. When reprocessing protocols are insufficient, the resulting infections deplete hospital budgets that could otherwise fund new equipment purchases. According to the Association for Professionals in Infection Control and Epidemiology, in 2024, surgical site infections resulted in an average hospital stay extension of nearly 10 days and an estimated $20,000 in additional hospitalization costs per patient. This profound economic burden forces institutions to prioritize infection control compliance and remediation over the acquisition of new surgical devices, thereby directly stifling broader market growth.
Market Trends
The market is being reshaped by the rising adoption of single-use disposable retractors, driven by the critical need to mitigate surgical site infections and eliminate complex reprocessing workflows. These devices are increasingly integrating advanced features such as cordless LED illumination to enhance visualization in deep cavities without the logistical burden of fiber optic cables. This shift is evident in the financial performance of key manufacturers investing in disposable technologies to meet heightened sterilization standards. According to CooperCompanies, May 2025, in the 'Second Quarter 2025 Earnings Call', the company reported that its OBP Surgical portfolio of single-use cordless surgical retractors generated 31% revenue growth, underscoring the rapid clinical acceptance of these sterile, ready-to-use instruments.
Concurrently, the growing demand for compact retractor systems in Ambulatory Surgery Centers (ASCs) is accelerating as high-acuity procedures migrate from inpatient hospital settings to outpatient environments. This transition necessitates specialized, space-efficient instrumentation designed to handle complex orthopedic and reconstruction cases within the streamlined infrastructure of an ASC. The expansion of outpatient arthroplasty, for instance, requires robust yet ergonomic retractors that function effectively in smaller operating rooms. According to Surgery Partners, November 2025, in the 'Third Quarter 2025 Earnings Call', the volume of total joint replacement surgeries performed in its ambulatory facilities grew 23% year-to-date, signaling a substantial increase in the utilization of procedure-specific retraction hardware tailored for outpatient surgical suites.
Report Scope
In this report, the Global Surgical Retractors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Surgical Retractors Market.
Global Surgical Retractors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: